Stefano D’Ardìa
About
Stefano D’Ardìa is a scholar working on Hematology, Oncology and Molecular Biology.
According to data from OpenAlex, Stefano D’Ardìa has authored 26 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 8 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Stefano D’Ardìa's work include Acute Myeloid Leukemia Research (14 papers), Neutropenia and Cancer Infections (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Stefano D’Ardìa is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Neutropenia and Cancer Infections (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Stefano D’Ardìa collaborates with scholars based in Italy, Germany and United States. Stefano D’Ardìa's co-authors include Alessandro Busca, Ernesta Audisio, Chiara Frairia, Michele Falda, Franco Locatelli, Filippo Marmont, Chiara Maria Dellacasa, Semra Aydin, Giovannino Ciccone and Valentina Giai and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.
In The Last Decade
Stefano D’Ardìa
25 papers receiving 301 citations
Peers
Stefano D’Ardìa
Chiara Frairia Italy
Sophie Dimicoli United States
Mariagiovanna Cefalo Italy
Jasmita Dass India
Sumita Saluja India
Elisa Cerqui Italy
Johanna Konopacki France
Srinivas Devarakonda United States
Tuphan Kanti Dolai India
Mark Vander Lugt United States
Citations per year, relative to Stefano D’Ardìa Stefano D’Ardìa (= 1×)
peers
Chiara Frairia
Countries citing papers authored by Stefano D’Ardìa
Since
Specialization
Citations
This map shows the geographic impact of Stefano D’Ardìa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano D’Ardìa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano D’Ardìa more than expected).
Fields of papers citing papers by Stefano D’Ardìa
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Stefano D’Ardìa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano D’Ardìa. The network helps show where Stefano D’Ardìa may publish in the future.
Co-authorship network of co-authors of Stefano D’Ardìa
This figure shows the co-authorship network connecting the top 25 collaborators of Stefano D’Ardìa. A scholar is included among the top collaborators of Stefano D’Ardìa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano D’Ardìa. Stefano D’Ardìa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
D’Ardìa, Stefano, Chiara Frairia, Valentina Giai, et al.. (2023). Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience. Leukemia Research. 136. 107421–107421.
2.
Frairia, Chiara, Emanuela Messa, Alessandro Busca, et al.. (2023). Validation of National Early Warning Score and Quick Sequential (sepsis‐related ) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy . European Journal Of Haematology. 110(6). 696–705.
3.
Aydin, Semra, Roberto Passera, Marco Cerrano, et al.. (2023). Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center Analysis. Cancers. 15(4). 1002–1002.
4.
Arrigo, Giulia, Stefano D’Ardìa, Chiara Frairia, et al.. (2023). Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors. Cancers. 15(13). 3512–3512.
5.
Frairia, Chiara, Alessandro Busca, Silvia Corcione, et al.. (2023). Levofloxacin prophylaxis omission in acute myeloid leukemia during post induction aplasia: a single center study. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023022–e2023022.
6.
Cerrano, Marco, Daniela Di Cuonzo, Stefano D’Ardìa, et al.. (2022). Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study. Annals of Hematology. 101(4). 855–867.
7.
Arrigo, Giulia, Stefano D’Ardìa, Ernesta Audisio, et al.. (2022). Gilteritinib in Isolated Breast Relapse of <b><i>FLT3</i></b> Positive Acute Myeloid Leukemia: A Case Report and Review of Literature. Acta Haematologica. 145(5). 566–570.
8.
Aydin, Semra, Stefano D’Ardìa, Massimo Massaia, et al.. (2021). CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1. Scientific Reports. 11(1). 21230–21230.
9.
D’Ardìa, Stefano, Chiara Frairia, Valentina Giai, et al.. (2021). Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021. Cancers. 13(20). 5075–5075.
10.
Efficace, Fabio, Massimo Breccia, Giuseppe Avvisati, et al.. (2018). Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia. Leukemia. 33(7). 1598–1607.
11.
Frairia, Chiara, et al.. (2018). Sparing Anti-Bacterial Prophylaxis in Acute Myeloid Leukemia during Post Induction Aplasia Does Not Impact on Bacteriemiae Incidence and Early Death: A Retrospective Single Center Study. Blood. 132(Supplement 1). 4001–4001.
12.
Brunello, Lucia, Roberto Passera, Chiara Maria Dellacasa, et al.. (2018). Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients. Annals of Hematology. 97(11). 2205–2215.
13.
Frairia, Chiara, Semra Aydin, Ernesta Audisio, et al.. (2017). Post-remissional and pre-transplant role of minimal residual disease detected by WT1 in acute myeloid leukemia: A retrospective cohort study. Leukemia Research. 61. 10–17.
14.
Riera, Ludovica, Filippo Marmont, Chiara Frairia, et al.. (2013). Core binding factor acute myeloid leukaemia and c-KIT mutations. Oncology Reports. 29(5). 1867–1872.
15.
Busca, Alessandro, Clara Pecoraro, Luisa Giaccone, et al.. (2013). Allogeneic stem cell transplant for adults with myelodysplastic syndromes: relevance of pre-transplant disease status. Leukemia & lymphoma. 55(4). 863–869.
16.
Dellacasa, Chiara Maria, Alessandro Busca, Ernesta Audisio, et al.. (2013). Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles. Journal of Chemotherapy. 26(5). 315–320.
17.
Busca, Alessandro, Franco Locatelli, Stefano D’Ardìa, et al.. (2011). Blood stream infections after allogeneic stem cell transplantation: a single‐center experience with the use of levofloxacin prophylaxis. Transplant Infectious Disease. 14(1). 40–48.
18.
Busca, Alessandro, Franco Locatelli, Giovannino Ciccone, et al.. (2010). In vivo T‐cell depletion with pretransplant low‐dose antithymocyte globulin is associated with reduced transplant‐related mortality and improved clinical outcome in patients receiving allogeneic hematopoietic stem cell transplantation from unrelated and partially matched related donors. American Journal of Hematology. 86(2). 214–217.
19.
Busca, Alessandro, Michele Falda, Paola Manzini, et al.. (2009). Iron Overload in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: Quantification of Iron Burden by a Superconducting Quantum Interference Device (SQUID) and Therapeutic Effectiveness of Phlebotomy. Biology of Blood and Marrow Transplantation. 16(1). 115–122.
20.
Palumbo, Antonio, Letizia Canepa, Stefano D’Ardìa, et al.. (2006). Oral lenalidomide plus melphalan and prednisone (R-MP) for newly diagnosed multiple myeloma. Journal of Clinical Oncology. 24(18_suppl). 7518–7518.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Chiara Frairia Breakdown of academic impact, for papers by Sophie Dimicoli Breakdown of academic impact, for papers by Mariagiovanna Cefalo Breakdown of academic impact, for papers by Jasmita Dass Breakdown of academic impact, for papers by Sumita Saluja Breakdown of academic impact, for papers by Elisa Cerqui Breakdown of academic impact, for papers by Johanna Konopacki Breakdown of academic impact, for papers by Srinivas Devarakonda Breakdown of academic impact, for papers by Tuphan Kanti Dolai Breakdown of academic impact, for papers by Mark Vander Lugt